A detailed history of Schroder Investment Management Group transactions in Glaukos Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 3,268 shares of GKOS stock, worth $507,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,268
Previous 3,268 -0.0%
Holding current value
$507,193
Previous $386,000 10.1%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$89.48 - $118.35 $292,420 - $386,767
3,268 New
3,268 $386,000
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $1,523 - $1,739
22 Added 0.05%
44,840 $3.37 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $1.34 Million - $2.1 Million
29,491 Added 192.41%
44,818 $3.19 Million
Q1 2023

May 11, 2023

BUY
$43.88 - $52.48 $672,548 - $804,360
15,327 New
15,327 $767,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.39B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.